Similar articles

• Comparison of therapeutic response to long-term treatment with lecithin versus piracetam plus lecithin in patients with Alzheimer's disease.

  Smith RC, Vroulis G, Johnson R, Morgan R. Smith RC, et al. Psychopharmacol Bull. 1984 Summer;20(3):542-5. Psychopharmacol Bull. 1984. PMID: 6433396 Clinical Trial. No abstract available.
• Piracetam combined with lecithin in the treatment of Alzheimer's disease.

  Growdon JH, Corkin S, Huff FJ, Rosen TJ. Growdon JH, et al. Neurobiol Aging. 1986 Jul-Aug;7(4):269-76. doi: 10.1016/0197-4580(86)90007-2. Neurobiol Aging. 1986. PMID: 3528889 Clinical Trial.
• Lecithin and piracetam in Alzheimer's disease.

  Davidson M, Mohs RC, Hollander E, Zemishlany Z, Powchik P, Ryan T, Davis KL. Davidson M, et al. Biol Psychiatry. 1987 Jan;22(1):112-4. doi: 10.1016/0006-3223(87)90139-9. Biol Psychiatry. 1987. PMID: 3790634 No abstract available.
• [Alzheimer's disease therapy--theory and practice].

  Gabryelewicz T, Barcikowska M, Jarczewska DL. Gabryelewicz T, et al. Wiad Lek. 2005;58(9-10):528-35. Wiad Lek. 2005. PMID: 16529064 Review. Polish.
• [Piracetam, nimodipine and tacrine in the pharmacologic treatment of dementia: bibliographic review].

  Ojer Tsakiridu D, Dosantos Hernández JO, Larrabe Medina J, Sánchez Casado JI, Sologuren Echenagusia A. Ojer Tsakiridu D, et al. Aten Primaria. 1996 Sep 30;18(5):257-60, 262-4. Aten Primaria. 1996. PMID: 8936720 Review. Spanish. No abstract available.